Potentiation of cutaneous reactivity and blood leucocyte histamine release by deuterium oxide in human beings
- PMID: 62485
- DOI: 10.1111/j.1398-9995.1976.tb01696.x
Potentiation of cutaneous reactivity and blood leucocyte histamine release by deuterium oxide in human beings
Abstract
Deuterium oxide (D2O) is known to potentiate non-cytotoxic histamine release in vitro. It has been shown (5) that D2O could also potentiate in vivo immediate-type hypersensitivity in dogs and monkeys. Present studies demonstrate potentiation in vivo by D2O of the cutaneous reactivity in 48/80, PHA and Dermatophagoides cutaneous reactions in human beings. PHA histamine release from human leucocytes is also potentiated by D2O in vitro.
Similar articles
-
Potentiation of IgE-mediated cutaneous reactivity and blood leucocyte histamine release by deuterium oxide.Clin Exp Immunol. 1975 Feb;19(2):335-42. Clin Exp Immunol. 1975. PMID: 55323 Free PMC article.
-
Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.Am Rev Respir Dis. 1984 Apr;129(4):592-6. Am Rev Respir Dis. 1984. PMID: 6201094
-
Hypersensitivity responses in monkeys. Histamine, skin response, 48-80, passive transfer (man to monkey, monkey to monkey) and other features related to human reactivity.Ann Allergy. 1968 Mar;26(3):99-106. Ann Allergy. 1968. PMID: 4171293 No abstract available.
-
Microtubules, cyclic AMP, calcium, and secretion.Ann N Y Acad Sci. 1975 Jun 30;253:771-9. doi: 10.1111/j.1749-6632.1975.tb19245.x. Ann N Y Acad Sci. 1975. PMID: 50038 Review. No abstract available.
-
Agents that release histamine from mast cells.Annu Rev Pharmacol Toxicol. 1983;23:331-51. doi: 10.1146/annurev.pa.23.040183.001555. Annu Rev Pharmacol Toxicol. 1983. PMID: 6191653 Review. No abstract available.